LFCR EBITDA Growth
Lifecore Biomedical Inc · EBITDA Growth
LFCR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-124.62%period ending
LFCR TTM EBITDA YoY % (-90.00% → -124.62%)
Year-over-year change
High-resolution chart · PNG
LFCR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -124.6173% | |
| -214.5041% | |
| 218.2368% | |
| 195.8929% | |
| 230.4186% | |
| 135.8263% | |
| 60.4906% | |
| -95.3832% | |
| -69.2483% | |
| -272.3182% | |
| -219.3171% | |
| -345.4859% | |
| -604.4744% | |
| 195.0843% | |
| 168.4758% | |
| 123.8344% | |
| 89.9327% | |
| -1,254.0281% | |
| -333.5955% | |
| -247.8834% | |
| -199.3699% | |
| -105.8555% | |
| -37.4219% | |
| -16.326% | |
| -15.8739% | |
| 31.5504% | |
| 12.2659% | |
| -6.7573% | |
| -4.6369% | |
| -38.4205% | |
| 416.7083% | |
| 425.6521% | |
| 387.953% | |
| 374.6751% | |
| -128.0068% | |
| -130.5303% | |
| -139.2258% | |
| -149.3951% | |
| -11.1833% | |
| -6.5234% | |
| -22.7112% | |
| -28.6033% | |
| -5.0392% | |
| -28.3428% | |
| -16.6536% | |
| -8.7918% | |
| -9.4579% | |
| 66.4773% | |
| 108.2572% | |
| 231.695% | |
| 173.0554% | |
| 83.6735% | |
| 38.8775% | |
| -29.9352% | |
| -15.6472% | |
| 5.3592% | |
| 28.1135% | |
| 14.178% | |
| 5.3329% | |
| -14.5997% | |
| -33.8494% | |
| -9.323% | |
| -24.0046% | |
| -27.3228% | |
| -14.2194% | |
| -22.3996% | |
| -55.1882% | |
| -46.8083% | |
| -44.2392% | |
| -45.1539% | |
| 197.0908% | |
| 195.9573% | |
| 175.0429% | |
| 263.6926% | |
| 49.9235% | |
| 32.3294% | |
| 28.9013% | |
| 2.9805% | |
| 12.2867% | |
| 24.9474% | |
| 22.2007% | |
| 23.149% | |
| 61.7431% | |
| 41.4217% | |
| 51.7302% | |
| 32.723% | |
| 5.8638% | |
| 60.0834% | |
| 68.0355% | |
| 215.3072% | |
| 148.8494% | |
| -24.3237% | |
| -48.7628% | |
| -63.8106% | |
| -68.5526% | |
| 61.8387% | |
| 3,908.3333% | |
| 635.6263% | |
| 795.6522% | |
| 454.1344% |